[Yung Shin] Announcement of Important Resolutions of the 2026 Annual General Meeting
Yung Shin Pharmaceutical held its Annual General Meeting on May 27, 2026, approving the 2025 earning… · 2026-05-27
永信 News Releases
[Yung Shin] Announcement of the Approval of Non-Compete Restriction Removal for Directors at the 2026 Annual General Meeting
Yung Shin Pharmaceutical announced that the 2026 AGM approved the removal of non-compete restriction… · 2026-05-27
[YungShin] Announcement on behalf of major subsidiary YungShin Pharm IND. Co., Ltd. regarding the leak of consumer information from a third-party vendor's campaign website
YungShin Pharm announced a data breach on a third-party vendor's inactive campaign site, potentially… · 2026-05-15
[YungShin] Announcement on behalf of major subsidiary YungShin Pharm IND. Co., Ltd. regarding the leak of consumer information from a third-party vendor's campaign website
YungShin Pharm announced a data breach on a third-party vendor's inactive campaign site, potentially… · 2026-05-15
Yung Shin Announces Board Resolution for Simple Merger between Subsidiary Yung Shin Formosa Investment Holding Co., Ltd. and Yung Shin International Investment Holding Co., Ltd.
Yung Shin International Investment Holding and its wholly-owned subsidiary, Yung Shin Formosa Invest… · 2026-05-06
【Yungshin】Announcement on the Company's Board of Directors Approving the Q1 2026 Consolidated Financial Report
Yungshin announced that its Board of Directors approved the consolidated financial report for the fi… · 2026-05-06
【Yungshin】Announcement on the Company's Board of Directors Approving the Q1 2026 Consolidated Financial Report
Yungshin announced that its Board of Directors approved the consolidated financial report for the fi… · 2026-05-06
【Yung Shin】Announcement of the Company's Acquisition of Right-of-Use Assets from a Related Party (Early Termination of Lease Agreement)
Yung Shin announced the early termination of a property lease agreement with its subsidiary, Yung Sh… · 2026-05-06
【Everlight】The company's Board of Directors resolved to proceed with a simple merger with Everlight Formosa Investment Holding Co., Ltd. in accordance with Article 19 of the Business Mergers and Acquisitions Act
Everlight International Investment Holding Co., Ltd. announced a resolution by its Board of Director… · 2026-05-06
【Yung Shin】Announcement of the Company's Acquisition of Right-of-Use Assets from a Related Party (Early Termination of Lease Agreement)
Yung Shin announced the early termination of a property lease agreement with its subsidiary, Yung Sh… · 2026-05-06
【Everlight】The company's Board of Directors resolved to proceed with a simple merger with Everlight Formosa Investment Holding Co., Ltd. in accordance with Article 19 of the Business Mergers and Acquisitions Act
Everlight International Investment Holding Co., Ltd. announced a resolution by its Board of Director… · 2026-05-06
Yung Shin Announces Board Resolution for Simple Merger between Subsidiary Yung Shin Formosa Investment Holding Co., Ltd. and Yung Shin International Investment Holding Co., Ltd.
Yung Shin International Investment Holding and its wholly-owned subsidiary, Yung Shin Formosa Invest… · 2026-05-06
【YUNG SHIN】Announcement by Important Subsidiary Yung Shin Pharmaceutical Industrial Co., Ltd. Regarding Important Board Resolutions
Yung Shin Pharmaceutical Industrial Co., Ltd., an important subsidiary of Yung Shin, announced board… · 2026-05-05
【Yongxin】Announcement by Important Subsidiary Yongxin Pharmaceutical Industrial Co., Ltd. Regarding the Record Date for 2025 Cash Dividend Distribution
Yongxin Pharmaceutical Industrial Co., Ltd., a major subsidiary of Yongxin, announced the record dat… · 2026-05-05
【YUNG SHIN】Announcement by Important Subsidiary Yung Shin Pharmaceutical Industrial Co., Ltd. Regarding Important Board Resolutions
Yung Shin Pharmaceutical Industrial Co., Ltd., an important subsidiary of Yung Shin, announced board… · 2026-05-05
【Yongxin】Announcement by Important Subsidiary Yongxin Pharmaceutical Industrial Co., Ltd. Regarding the Record Date for 2025 Cash Dividend Distribution
Yongxin Pharmaceutical Industrial Co., Ltd., a major subsidiary of Yongxin, announced the record dat… · 2026-05-05
[Yungshin] May 2026 Revenue Reaches NT$658 Million (Down 3.2% YoY)
Yungshin (3705) announced its consolidated revenue for May 2026, totaling NT$657.96 million (approx.… · 2026-05-01
【Yung Shin】Announcement of the Company's Q1 115 Financial Report; Board of Directors Meeting Scheduled for May 6, 115 (ROC Calendar)
Yung Shin announced that its board of directors will hold a meeting on May 6, 115 (Republic of China… · 2026-04-28
【Yung Shin】Announcement of the Company's Q1 115 Financial Report; Board of Directors Meeting Scheduled for May 6, 115 (ROC Calendar)
Yung Shin announced that its board of directors will hold a meeting on May 6, 115 (Republic of China… · 2026-04-28
Yung Shin Reports April 2026 Revenue of NT$694 Million, Down 1.5% Year-on-Year
Yung Shin (stock code: 3705) announced its revenue for April 2026, totaling NT$693.85 million (appro… · 2026-04-01
Yung Shin Reports April 2026 Revenue of NT$694 Million, Down 1.5% Year-on-Year
Yung Shin (stock code: 3705) announced its revenue for April 2026, totaling NT$693.85 million (appro… · 2026-04-01
[Yung Shin] March 2026 Revenue NT$620 Million (YoY -23.7%)
Yung Shin Pharmaceutical announced its March 2026 monthly revenue was NT$620 million, a sharp decrea… · 2026-03-01
[Yung Shin] March 2026 Revenue NT$620 Million (YoY -23.7%)
Yung Shin Pharmaceutical announced its March 2026 monthly revenue was NT$620 million, a sharp decrea… · 2026-03-01
【Yung Shin】February 2026 Monthly Revenue NT$524 Million (YoY -16.7%)
Taiwan's major pharmaceutical manufacturer, Yung Shin (3705), announced its financial data for Febru… · 2026-02-01
【Yung Shin】February 2026 Monthly Revenue NT$524 Million (YoY -16.7%)
Taiwan's major pharmaceutical manufacturer, Yung Shin (3705), announced its financial data for Febru… · 2026-02-01